Evidence map›Paper›PMID 21681612›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2011

Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy.

Chiara Marchesi, Rachid Essalmani, Catherine A Lemarié, Eyal Leibovitz, Talin Ebrahimian, Pierre Paradis, Nabil G Seidah, Ernesto L Schiffrin, Annik Prat

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine?Journal of molecular medicine (Berlin, Germany) · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Chiara MarchesiLady Davis Institute for Medical Research, Montreal, Quebec, Canada.
Rachid Essalmani
Catherine A Lemarié
Eyal Leibovitz
Talin Ebrahimian
Pierre Paradis
Nabil G Seidah
Ernesto L Schiffrin
Annik Prat
Jewish General Hospital · CAUniversité de Montréal · CAMcGill University · CAMontreal Clinical Research Institute · CA

Funding

Canadian Institutes of Health Research CTP82946Canadian Institutes of Health Research MOP44363Canadian Institutes of Health Research MOP82790
6 · The paper itself

Abstract

Proprotein convertase (PC) 5/6 belongs to a family of secretory proteases involved in proprotein proteolysis. Several studies suggest a role for PC5/6 in cardiovascular disease. Because lethality at birth of mice lacking PC5/6 precluded elucidation of its function in the adult, we generated mice in which the gene of PC5/6 (pcsk5) is specifically inactivated in endothelial cells (ecKO), which are viable and do not exhibit overt abnormalities. In order to uncover the function of PC5/6 in the cardiovascular system, the effect of ecKO was studied in aging mice. In 16 to 18-month-old ecKO mice, the left ventricle (LV) mass, media cross-sectional area of aorta and coronary arteries, and media-to-lumen ratio of mesenteric arteries were decreased. The LV presented decreased diastolic function, and mesenteric arteries showed decreased stiffness. Collagen was decreased in the LV myocardial interstitium and perivascularly in coronary arteries and aorta. Cardiovascular hypotrophy likely develops with aging, since no significant changes were observed in 2-month-old ecKO mice. Fibroblasts, as a source of collagen in myocardium and vasculature, may play a role in the decrease in collagen deposition. Fibroblasts co-cultured with ecKO endothelial cells showed decreased collagen production, decreased insulin-like growth factor (IGF)-1/Akt/mTOR signaling, and enhanced autophagic activation. PC5/6 inactivation in endothelial cells results in cardiovascular hypotrophy associated with decreased collagen deposition, decreased LV diastolic function, and vascular stiffness, suggesting a trophic role of endothelial PC5/6 in the cardiovascular system, likely mediated by IGF-1/Akt/mTOR signaling and control of autophagy.

Indexed as

AutophagyVascular StiffnessAnimalsCollagenCoronary VesselsEndothelial CellsFibroblastsHumansInsulin-Like Growth Factor IMiceMice, TransgenicMyocardiumOrgan SizeProprotein Convertase 5ProteolysisProto-Oncogene Proteins c-aktCollagenInsulin-Like Growth Factor ImTOR protein, mousepropeptide convertase 5, mouseProprotein Convertase 5Proto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID21681612
OpenAlexW2083550185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.